Navigation Links
Botaneco announces $4,000,000 financing
Date:6/30/2008

- Investment enables SemBioSys subsidiary to accelerate commercialization of personal care ingredients with its proprietary oleosome-based technology

-

TSX symbol: SBS

CALGARY, June 30 /PRNewswire-FirstCall/ - Botaneco Specialty Ingredients Inc. ('Botaneco'), a wholly-owned subsidiary of SemBioSys Genetics Inc. ('SemBioSys'), today announced that it has entered into an agreement for a $4.0 million convertible debenture financing with Avrio Ventures Limited Partnership ('Avrio Ventures'). Along with $2.4 million previously committed from AVAC Ltd., the funding will be used to accelerate Botaneco's commercialization of Hydresia(TM) products that target the personal care and topical ingredients markets. In consideration of prior investments made, SemBioSys received debentures from Botaneco totaling $5 million. Excluding the SemBioSys debentures, the transaction assigned Botaneco a pre-money valuation of $12.5 million.

"This transaction provides Botaneco with the financial resources necessary to aggressively pursue opportunities in the personal care, over-the-counter (OTC) and topical pharmaceutical markets completely independent of SemBioSys. This is the latest in a series of steps we have made to provide Botaneco with the technology, people and capital to operate as a separate entity and achieve its full potential. It also allows SemBioSys to focus its resources specifically on our pharmaceutical pipeline," said Andrew Baum, president and chief executive officer of SemBioSys. "Dozens of companies are now developing consumer products with Hydresia(TM), and we expect to see a further array of product launches based on these ingredients in the coming quarters."

Hydresia(TM), a natural product, is derived from safflower seeds and offers unique functionality and aesthetic properties without compromising performance. Strategically positioned to lead the natural personal care move
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation
2. Botaneco Announces Launch of Second Generation Oleosome Product
3. Botaneco obtains $2.4 million in funding from AVAC
4. EnterPrize Business Plan Competition Announces Final Phase Winners of Cash Awards Totaling $45,000
5. Wyeth Announces Bernard Poussot Assumes Chairman of the Board Position
6. Dragon Pharma Announces Results of the Annual General Meeting
7. Barr Announces Favorable Ruling in Mirapex(R) Patent Challenge
8. Impact Systems Announces Completion of Successful Enterprise Content Migrations to Documentum 6
9. ValGenesis, Inc. Announces Worldwide Release of Validation Life Cycle Management System - ValGenesis 2.0
10. Wyeth Pharmaceuticals Announces Organizational Change
11. Spectral announces continuing support for the combination of EAA(TM) and anti-endotoxin therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... The Europe Thermal Protective Clothing market report ... revenue forecasts. It estimates the market to reach ... of 7.5%, from 2013 to 2018. , Browse ... Clothing market report for a glimpse of the ... tables and figures. , http://www.micromarketmonitor.com/market/europe-thermal-protective-clothing-5957050557.html , ...
(Date:11/27/2014)... USA (PRWEB) November 26, 2014 Biomedical ... accuracy, additive systems to enable 3D manufacture at the ... road conditions are among finalists in nine categories for ... The awards are sponsored by SPIE, the international ... Media . , Winners will be announced by industry ...
(Date:11/26/2014)... Chicago, IL (PRWEB) November 26, 2014 ... is giving customers a bevy of last-minute Thanksgiving ... coupon codes and offers across all product lines this ... Thanksgiving. , Thanksgiving, Black Friday, and Cyber Monday ... expressing its' own thanks to both loyal customers and ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 The ... City’s award-winning technology innovation centers, announced today that ... closing on December 1st. “Do you have a ... so, I want to know about it. AccelerateBaltimore ... idea to product in just 13 weeks.” ...
Breaking Biology Technology:The Europe Thermal Protective Clothing market is estimated to grow up to $577.9 million by 2018 - Report by MicroMarket Monitor 2The Europe Thermal Protective Clothing market is estimated to grow up to $577.9 million by 2018 - Report by MicroMarket Monitor 3Finalists Named for 2015 Prism Awards for Photonics Innovation 2Finalists Named for 2015 Prism Awards for Photonics Innovation 3Finalists Named for 2015 Prism Awards for Photonics Innovation 4Finalists Named for 2015 Prism Awards for Photonics Innovation 5DNA Spectrum Offers Last Minute Thanksgiving Coupons 2DNA Spectrum Offers Last Minute Thanksgiving Coupons 3AccelerateBaltimore Applications to Close in 6 Days 2AccelerateBaltimore Applications to Close in 6 Days 3
... Coalition,s Annual Meeting, FREMONT, Calif., Sept. 8 ... announced today that a,team of scientists at Stanford University ... at the Annual General Meeting of the,PAD Coalition. Led ... Eric T.,Fung, Chief Scientific Officer at Vermillion, Inc., the ...
... Sept. 8 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, ... enrolment in a Phase 2 clinical trial using ... in patients with advanced head and neck cancers. ... Cancer Therapy & Research Center,(CTRC) at The University ...
... International,Inc. (Nasdaq: CHDX ), a leading independent American provider ... China, today,announced that the Company will appear at the following ... held at the Grand Hyatt Hotel ... available for this event. -- ...
Cached Biology Technology:Vermillion and Stanford Scientists Receive 'Best Research Award' From the PAD Coalition 2Vermillion and Stanford Scientists Receive 'Best Research Award' From the PAD Coalition 3Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin 2Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin 3Chindex International, Inc. Announces Appearances at Upcoming Investor Conferences 2Chindex International, Inc. Announces Appearances at Upcoming Investor Conferences 3
(Date:11/7/2014)... Dr. Debra Auguste, associate professor, biomedical engineering, in ... College of New York, have identified a molecule ... of the most aggressive forms of breast cancer. ... high mortality rate owing to aggressive proliferation and ... However, Professor Auguste,s team, discovered the overexpression of ...
(Date:11/6/2014)... that predator runs so fast that it essentially blinds itself. ... fastest creature on Earth. Some of these half-inch-long beetles cover ... per hour). The fastest human can do about five body ... a person would have to hit 480 miles per hour. ... speeds, everything becomes a blur. They can,t gather enough light ...
(Date:11/4/2014)... Nov. 5, 2014 – University of Utah engineers developed ... help jet fuel produce electricity without needing to ignite ... to power portable electronics, off-grid power and sensors. , ... in the American Chemical Society journal ACS Catalysis ... a chemical reaction between a fuel and an oxygen-rich ...
Breaking Biology News(10 mins):The tiger beetle: Too fast to see 2Jet-fueled electricity at room temperature 2
... An international team led by scientists at The ... and Albert Einstein College of Medicine of Yeshiva University ... attacks the tuberculosis (TB) bacterium in two different ways. ... one of the major global health crises of our ...
... professors in Wayne State University,s Department of Physics kicked ... for Undergraduates (REU) program. This program aims to give ... and in particle and nuclear physics. According ... State,s College of Liberal of Arts, principal investigator and ...
... foundations with more modern elements. Using this same approachbut ... Dietrich School of Arts and Sciences have designed a ... storage, and gas transport more efficient and at a ... issue of the Journal of the American Chemical ...
Cached Biology News:New compound excels at killing persistent and drug-resistant tuberculosis 2New compound excels at killing persistent and drug-resistant tuberculosis 3New compound excels at killing persistent and drug-resistant tuberculosis 4Wayne State welcomes undergraduates from around the US for physics research experience 2'Chemical architects' build materials with potential applications in drug delivery and gas storage 2
Recombinant Ovine (Sheep) Prolactin, Ultra Pure...
Human SCP3 Affinity Purified Polyclonal Ab Keywords: Spermatogenesis, meiosis Protein Family: Cell Cycle...
Homo sapiens alcohol dehydrogenase 5 (class III), chi polypeptide (ADH5), mRNA....
Human Rad1 MAb (Clone 33)...
Biology Products: